Also, omalizumab significantly reduced RNA and protein levels of IL-6, IL-8,TNFα and IL-4 in a dose-dependent manner in IgE-stimulated human airway smooth muscle cells isolated from biospsy specimens of patients with asthma, chronic obstructive pulmonary disease and healthy controls [15]. This evidence concerns the gene IL6 and asthma.